| 000 | 00946 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250516232702.0 | ||
| 264 | 0 | _c20150304 | |
| 008 | 201503s 0 0 eng d | ||
| 022 | _a1879-0429 | ||
| 024 | 7 |
_a10.1016/j.copbio.2014.08.004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSpahn, Philipp N | |
| 245 | 0 | 0 |
_aSystems glycobiology for glycoengineering. _h[electronic resource] |
| 260 |
_bCurrent opinion in biotechnology _cDec 2014 |
||
| 300 |
_a218-24 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aBiopharmaceutics |
| 650 | 0 | 4 | _aGlycosylation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMetabolic Engineering |
| 650 | 0 | 4 |
_aRecombinant Proteins _xmetabolism |
| 700 | 1 | _aLewis, Nathan E | |
| 773 | 0 |
_tCurrent opinion in biotechnology _gvol. 30 _gp. 218-24 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.copbio.2014.08.004 _zAvailable from publisher's website |
| 999 |
_c24173102 _d24173102 |
||